Albert Robichaud Sage Therapeutics, Inc. (SAGE) insider trading activity
Albert Robichaud is Chief Scientific Officer of Sage Therapeutics, Inc.. Currently has a direct ownership of 145,553 shares of SAGE, which is worth approximately $791,808. The most recent transaction as insider was on Feb 03, 2023, when has been sold 1,127 shares (Common Stock) at a price of $44.16 per share, resulting in proceeds of $49,768. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
146K
0%
3M change
0%
12M change
Total Value Held
$791,808
Albert Robichaud Transaction History
AR
Albert Robichaud
Chief Scientific Officer
Cambridge, MA